Transcutaneous vagus nerve stimulation in sleep disorders: current evidence and future directions
By
Frédéric Roche
Mathilde Monier
Lytissia Mouhli Gasmi
Vincent Pichot
July 16, 2026
Clinical Scorecard: Transcutaneous Vagus Nerve Stimulation for Sleep Disorders: Current Insights and Future Perspectives
At a Glance
Category Detail
Condition Sleep Disorders Key Mechanisms Non-invasive neuromodulation via transcutaneous vagus nerve stimulation (tVNS) targeting autonomic nervous system regulation. Target Population Individuals with various sleep disorders including chronic insomnia, PTSD-related sleep disturbances, and obstructive sleep apnea. Care Setting Clinical settings focusing on neuropsychiatric conditions.
Key Highlights
tVNS shows promise in managing chronic insomnia with evidence from multiple randomized controlled trials. Pilot studies suggest potential benefits of tVNS for PTSD-related sleep disturbances, though findings are preliminary. No controlled trials have assessed tVNS effects on obstructive sleep apnea. Guideline-Based Recommendations
Diagnosis
Consider tVNS in patients with chronic insomnia based on available evidence. Management
Utilize tVNS as a non-invasive treatment option for sleep disorders, particularly chronic insomnia. Monitoring & Follow-up
Monitor patient responses to tVNS, especially in terms of sleep quality and related symptoms. Risks
Be aware of the limitations and lack of controlled trials for tVNS in conditions like obstructive sleep apnea. Patient & Prescribing Data
Patients with chronic insomnia, PTSD, and other sleep disorders.
tVNS may lead to significant improvements in sleep quality metrics such as PSQI scores.
Clinical Best Practices
Conduct thorough assessments of sleep disorders before considering tVNS. Incorporate tVNS as part of a multidisciplinary approach to managing sleep disorders. Related Resources & Content
